The influenza virus snatches the cap part of the mature host RNA to start viral replication. MTr1-deficient cells or cells treated with MTr1 inhibitors do not lead to IAV replication.
To date clinical studies often show a poor B cell-mediated antibody response after an infection or vaccination in those with ...